FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution
Status: Discontinuation
»Therapeutic Categories: Pediatric; Pulmonary/Allergy

Perrigo Pharmaceuticals (New 06/05/2018)

Company Contact Information:

Presentation Posting Date Related Information
Hydrocodone Bitartrate (5 mg/5 mL) and Homatropine Methylbromide (1.5 mg/5 mL)(NDC 0574-1105-16) 06/05/2018 The discontinuation of this product is a business decision

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English